Table 2.
Echocardiography measurements for cardiac functions of DOX-induced cardiomyopathy mice
| Genotypes | EF(%) | FS(%) | LVID; d(mm) | LVID; s(mm) | LV Vol; d(ul) | LV Vol; s(ul) |
|---|---|---|---|---|---|---|
| IKKαflox/flox + Saline | 64.29 ± 2.03 | 34.53 ± 1.41 | 3.71 ± 0.10 | 2.51 ± 0.12 | 58.95 ± 3.87 | 24.01 ± 2.36 |
| IKKαLyz−2−cre + Saline | 61.91 ± 1.03 | 32.57 ± 0.95 | 3.75 ± 0.10 | 2.53 ± 0.09 | 62.76 ± 3.97 | 25.37 ± 2.79 |
| IKKαflox/flox + DOX |
50.22 ± 1.44 #, p < 0.0001 |
25.27 ± 0.67 #, p < 0.0001 |
4.19 ± 0.13 #, p < 0.0001 |
3.05 ± 0.13 #, p < 0.0001 |
69.39 ± 2.95 #, p = 0.0004 |
35.84 ± 2.33 #, p < 0.0001 |
| IKKαLyz−2−cre + DOX |
44.97 ± 1.36 †, p < 0.0001 |
20.96 ± 1.19 †, p < 0.0001 |
4.35 ± 0.15 †, p = 0.0842 |
3.33 ± 0.14 †, p = 0.0062 |
74.74 ± 4.48 †, p = 0.0347 |
46.70 ± 2.58 †, p < 0.0001 |
N = 6 each group (mean ± SEM)
#: IKKαflox/flox + DOX vs. IKKαflox/flox + Saline;
†: IKKαLyz−2−cre + DOX vs. IKKαflox/flox + DOX.